Patrick Weiss's most recent trade in Twist Bioscience Corp was a trade of 384 Common Stock done at an average price of $52.9 . Disclosure was reported to the exchange on April 1, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.91 per share. | 01 Apr 2022 | 384 | 47,401 (0%) | 0% | 52.9 | 20,317 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.21 per share. | 18 Feb 2022 | 1,124 | 47,785 (0%) | 0% | 53.2 | 59,808 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.87 per share. | 24 Jan 2022 | 288 | 48,909 (0%) | 0% | 55.9 | 16,091 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.39 per share. | 18 Jan 2022 | 188 | 49,197 (0%) | 0% | 77.4 | 14,549 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.39 per share. | 03 Jan 2022 | 242 | 49,385 (0%) | 0% | 77.4 | 18,728 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2021 | 6,057 | 49,627 (0%) | 0% | 0 | Common Stock | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 82.85 per share. | 21 Dec 2021 | 3,918 | 43,570 (0%) | 0% | 82.8 | 324,606 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 84.00 per share. | 14 Dec 2021 | 2,801 | 47,488 (0%) | 0% | 84 | 235,284 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2021 | 1,974 | 47,376 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.66 per share. | 14 Dec 2021 | 1,974 | 49,462 (0%) | 0% | 26.7 | 52,627 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.02 per share. | 14 Dec 2021 | 827 | 50,289 (0%) | 0% | 25.0 | 20,692 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2021 | 827 | 19,859 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 95.29 per share. | 24 Nov 2021 | 2,801 | 47,488 (0%) | 0% | 95.3 | 266,907 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.66 per share. | 24 Nov 2021 | 1,974 | 49,462 (0%) | 0% | 26.7 | 52,627 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2021 | 1,974 | 49,350 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.02 per share. | 24 Nov 2021 | 827 | 50,289 (0%) | 0% | 25.0 | 20,692 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2021 | 827 | 20,686 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 110.62 per share. | 19 Nov 2021 | 1,228 | 47,488 (0%) | 0% | 110.6 | 135,841 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.41 per share. | 22 Oct 2021 | 280 | 48,716 (0%) | 0% | 117.4 | 32,875 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 104.00 per share. | 13 Oct 2021 | 4,906 | 48,996 (0%) | 0% | 104 | 510,224 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2021 | 2,105 | 0 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. | 13 Oct 2021 | 2,105 | 51,101 (0%) | 0% | 8.8 | 18,566 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.66 per share. | 13 Oct 2021 | 1,974 | 53,075 (0%) | 0% | 26.7 | 52,627 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2021 | 1,974 | 51,324 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.02 per share. | 13 Oct 2021 | 827 | 53,902 (0%) | 0% | 25.0 | 20,692 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2021 | 827 | 21,513 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.50 per share. | 04 Oct 2021 | 236 | 48,996 (0%) | 0% | 105.5 | 24,898 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 112.52 per share. | 15 Sep 2021 | 4,905 | 49,232 (0%) | 0% | 112.5 | 551,911 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2021 | 2,104 | 2,105 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. | 15 Sep 2021 | 2,104 | 51,336 (0%) | 0% | 8.8 | 18,557 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.66 per share. | 15 Sep 2021 | 1,974 | 53,310 (0%) | 0% | 26.7 | 52,627 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2021 | 1,974 | 53,298 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2021 | 827 | 22,340 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.02 per share. | 15 Sep 2021 | 827 | 54,137 (0%) | 0% | 25.0 | 20,692 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.49 per share. | 20 Aug 2021 | 1,228 | 49,232 (0%) | 0% | 100.5 | 123,402 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 97.11 per share. | 18 Aug 2021 | 4,905 | 50,460 (0%) | 0% | 97.1 | 476,325 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. | 18 Aug 2021 | 2,104 | 52,564 (0%) | 0% | 8.8 | 18,557 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2021 | 2,104 | 4,209 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2021 | 1,974 | 55,272 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.66 per share. | 18 Aug 2021 | 1,974 | 54,538 (0%) | 0% | 26.7 | 52,627 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2021 | 827 | 23,167 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.02 per share. | 18 Aug 2021 | 827 | 55,365 (0%) | 0% | 25.0 | 20,692 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.34 per share. | 23 Jul 2021 | 280 | 50,460 (0%) | 0% | 117.3 | 32,855 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 119.75 per share. | 21 Jul 2021 | 4,905 | 50,740 (0%) | 0% | 119.8 | 587,374 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. | 21 Jul 2021 | 2,104 | 52,844 (0%) | 0% | 8.8 | 18,557 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jul 2021 | 2,104 | 6,313 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jul 2021 | 1,974 | 57,246 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.66 per share. | 21 Jul 2021 | 1,974 | 54,818 (0%) | 0% | 26.7 | 52,627 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jul 2021 | 827 | 23,994 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.02 per share. | 21 Jul 2021 | 827 | 55,645 (0%) | 0% | 25.0 | 20,692 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.48 per share. | 01 Jul 2021 | 236 | 50,740 (0%) | 0% | 131.5 | 31,029 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 118.34 per share. | 23 Jun 2021 | 4,905 | 50,976 (0%) | 0% | 118.3 | 580,458 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2021 | 2,104 | 8,417 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. | 23 Jun 2021 | 2,104 | 53,080 (0%) | 0% | 8.8 | 18,557 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2021 | 1,974 | 59,220 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.66 per share. | 23 Jun 2021 | 1,974 | 55,054 (0%) | 0% | 26.7 | 52,627 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.02 per share. | 23 Jun 2021 | 827 | 55,881 (0%) | 0% | 25.0 | 20,692 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2021 | 827 | 24,821 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.75 per share. | 20 May 2021 | 1,228 | 50,976 (0%) | 0% | 97.8 | 120,037 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 88.39 per share. | 19 May 2021 | 4,905 | 52,204 (0%) | 0% | 88.4 | 433,553 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2021 | 2,104 | 10,521 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. | 19 May 2021 | 2,104 | 54,308 (0%) | 0% | 8.8 | 18,557 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.66 per share. | 19 May 2021 | 1,974 | 56,282 (0%) | 0% | 26.7 | 52,627 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2021 | 1,974 | 61,194 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.02 per share. | 19 May 2021 | 827 | 57,109 (0%) | 0% | 25.0 | 20,692 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2021 | 827 | 25,648 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 133.12 per share. | 23 Apr 2021 | 280 | 52,204 (0%) | 0% | 133.1 | 37,274 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 124.42 per share. | 21 Apr 2021 | 4,906 | 52,484 (0%) | 0% | 124.4 | 610,405 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2021 | 2,105 | 12,625 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. | 21 Apr 2021 | 2,105 | 54,589 (0%) | 0% | 8.8 | 18,566 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.66 per share. | 21 Apr 2021 | 1,974 | 56,563 (0%) | 0% | 26.7 | 52,627 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2021 | 1,974 | 63,168 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2021 | 827 | 26,475 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.02 per share. | 21 Apr 2021 | 827 | 57,390 (0%) | 0% | 25.0 | 20,692 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.20 per share. | 01 Apr 2021 | 235 | 52,484 (0%) | 0% | 122.2 | 28,717 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.20 per share. | 01 Apr 2021 | 235 | 52,484 (0%) | 0% | 122.2 | 28,717 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 132.50 per share. | 24 Mar 2021 | 14,639 | 52,719 (0%) | 0% | 132.5 | 1,939,668 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2021 | 9,037 | 14,730 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. | 24 Mar 2021 | 9,037 | 61,756 (0%) | 0% | 8.8 | 79,706 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.66 per share. | 24 Mar 2021 | 3,948 | 65,704 (0%) | 0% | 26.7 | 105,254 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2021 | 3,948 | 65,142 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.02 per share. | 24 Mar 2021 | 1,654 | 67,358 (0%) | 0% | 25.0 | 41,383 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2021 | 1,654 | 27,302 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 150.81 per share. | 19 Feb 2021 | 1,126 | 52,719 (0%) | 0% | 150.8 | 169,812 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 190.64 per share. | 22 Jan 2021 | 263 | 53,845 (0%) | 0% | 190.6 | 50,138 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.29 per share. | 04 Jan 2021 | 242 | 54,108 (0%) | 0% | 141.3 | 34,192 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.66 per share. | 14 Dec 2020 | 25,662 | 83,596 (0%) | 0% | 26.7 | 684,149 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2020 | 25,662 | 69,090 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2020 | 10,754 | 28,956 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.02 per share. | 14 Dec 2020 | 10,754 | 94,350 (0%) | 0% | 25.0 | 269,065 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 147.13 per share. | 14 Dec 2020 | 7,751 | 59,468 (0%) | 0% | 147.1 | 1,140,382 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 140.75 per share. | 14 Dec 2020 | 5,652 | 83,396 (0%) | 0% | 140.8 | 795,531 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 146.15 per share. | 14 Dec 2020 | 5,476 | 67,219 (0%) | 0% | 146.1 | 800,306 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 139.84 per share. | 14 Dec 2020 | 5,302 | 89,048 (0%) | 0% | 139.8 | 741,422 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 141.62 per share. | 14 Dec 2020 | 5,057 | 78,339 (0%) | 0% | 141.6 | 716,159 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 147.95 per share. | 14 Dec 2020 | 5,018 | 54,450 (0%) | 0% | 148.0 | 742,431 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 142.92 per share. | 14 Dec 2020 | 3,718 | 74,621 (0%) | 0% | 142.9 | 531,381 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2020 | 3,584 | 23,767 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. | 14 Dec 2020 | 3,584 | 57,934 (0%) | 0% | 8.8 | 31,611 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 143.90 per share. | 14 Dec 2020 | 1,450 | 73,171 (0%) | 0% | 143.9 | 208,651 | Common Stock |
Twist Bioscience Corp | Patrick Weiss | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 145.01 per share. | 14 Dec 2020 | 476 | 72,695 (0%) | 0% | 145.0 | 69,026 | Common Stock |